Cidara Therapeutics Inc Shares Fall 2.7% Below Previous 52-Week Low - Market Mover
The shares fell 2.7% lower than its previous 52-week low of $1.10, with trading volume lower than its 30 day average
Jan 08, 2022 by Kwhen Finance Editors
Cidara Therapeutics Inc (CDTX) shares closed 2.7% lower than its previous 52 week low, giving the company a market cap of $76M. The stock is currently down 9.4% year-to-date, down 45.8% over the past 12 months, and down 89.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.7%.
Trading Activity
- Trading volume this week was 72.2% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
- The stock closed at 11.7% lower than its 5-day moving average, 19.1% lower than its 20-day moving average, and 36.3% lower than its 90-day moving average.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Cidara Therapeutics Inc | -7.0 | -9.4 | -45.8 | -63.8 | 3.6 |
| Dow Jones Industrial Average | -0.0 | -0.3 | 19.6 | -2.0 | 23.2 |
| S&P 500 Index | -0.4 | -1.5 | 26.9 | -2.5 | 28.8 |
| Health Care | -0.7 | -4.5 | 16.2 | -5.5 | 21.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 463.9%
- The company's stock price performance over the past 12 months lags the peer average by -973.1%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Cidara Therapeutics Inc | CDTX | 0 | -9.4 | -45.8 | -63.8 | 3.6 |
| Peer Avg | N/A | 41.7 | -1.7 | 5.2 | -35.7 | 19.3 |
| Alkermes plc | ALKS | -42.7 | 4.0 | 24.1 | -26.6 | 34.5 |
| Agenus Inc | AGEN | 209.4 | -4.7 | -7.0 | -55.1 | 22.0 |
| Alimera Sciences Inc. | ALIM | 0 | -6.0 | 3.9 | -61.2 | 20.6 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: